Blackmores Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blackmores Limited with three other
pharmaceutical manufacturers in Australasia:
Immuron Limited
(2017
sales of 2.98 million Australian Dollars [US$2.32 million]
),
TBG Diagnostics Ltd
(4.11 million Australian Dollars [US$3.20 million]
), and
Promisia Integrative Ltd
which is
based in New Zealand
(2.33 million New Zealand Dollars [US$1.71 million]
).
Sales Analysis.
Blackmores Limited reported sales of A$549.76 million (US$427.83 million)
for the
fiscal
year ending
June of 2017.
This
represents
a
sharp
decrease of 23.5%
versus 2016, when the company's sales were A$718.26 million.